You have 9 free searches left this month | for more free features.

Haploidentical donor transplantation

Showing 1 - 25 of 9,855

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +3 more
  • Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
  • Columbus, Ohio
  • +1 more
Apr 20, 2022

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Refractory Acute Myeloid Leukemia Trial in Paris (Sequential Packaging (SET), Transfusion graft, Prevention of GVHD)

Completed
  • Refractory Acute Myeloid Leukemia
  • Sequential Packaging (SET)
  • +4 more
  • Paris, France
    Service d'hématologie Clinique Hôpital Saint Antoine
Jul 22, 2022

Donor-recipient ABO Matching on Haploidentical Stem Cell

Completed
  • Hematological Malignancies
  • Haploidentical Stem Cell Transplantation
  • no intervention
  • Hangzhou, Zhejiang, China
  • +1 more
Oct 22, 2021

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Blood and Marrow Transplant
  • Minneapolis, Minnesota
    Masonic Caner Center at University of Minnesota
May 23, 2022

Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)

Recruiting
  • Relapsed Hematologic Malignancy
  • donor-derived CIK cells
  • Bergamo, Italy
    A O Papa Giovanni XXIII
Dec 22, 2021

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Sickle Cell Disease Trial (Haploidentical stem cell transplantation, Standard medical care)

Not yet recruiting
  • Sickle Cell Disease
  • Haploidentical stem cell transplantation
  • Standard medical care
  • (no location specified)
May 23, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell

Not yet recruiting
  • Hematologic Malignancy
  • Haplo-identical Stem Cell Transplantation
  • CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
  • (no location specified)
Oct 1, 2021

AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

Recruiting
  • AML
  • +2 more
  • Peripheral blood stem cells
  • Bonn, Germany
  • +8 more
Aug 25, 2021

Acute Myeloid Leukemia Trial in Los Angeles (Haploidentical IL-21-Expanded Natural Killer Cells)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • Haploidentical IL-21-Expanded Natural Killer Cells
  • Los Angeles, California
    Children's Hospital Los Angeles
Nov 1, 2021

HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia Trial in Austria, Germany (TCRa/ß+ and CD19+ depleted haploidentical stem

Recruiting
  • HbS Disease
  • +5 more
  • TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation
  • Matched sibling donor transplantation
  • Düsseldorf, Germany
  • +4 more
Jul 29, 2021

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 22, 2021

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)

Completed
  • Hematological Disease
  • +5 more
  • Total Body Irradiation 1200 cGy
  • +9 more
  • Rochester, New York
    Wilmot Cancer Institute
Nov 1, 2021